FDA inspection

National Cancer Institute, Cancer Therapy Evaluation Program: FDA inspection ending Jul 17, 2014

FDA inspection 891981 · Voluntary Action Indicated (VAI) · Bethesda, MD

Key facts

Inspection ID 891981
Firm National Cancer Institute, Cancer Therapy Evaluation Program
FEI number 3010830399
Address 31 Center Dr.
City Bethesda
State MD
ZIP 20892
Country United States
Fiscal year 2014
Inspection end date Jul 17, 2014
Classification Voluntary Action Indicated (VAI)
Project area Bioresearch Monitoring
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • Yes Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections